Reuters logo
BRIEF-Senzime submits application to FDA for approval of Tetragraph in U.S.
September 25, 2017 / 7:59 AM / 3 months ago

BRIEF-Senzime submits application to FDA for approval of Tetragraph in U.S.

Sept 25 (Reuters) - SENZIME AB (PUBL)

* SENZIME SUBMITS 510 (K) APPLICATION TO THE FDA

* HAS SUBMITTED A 510 (K) APPLICATION TO US FOOD AND DRUG ADMINISTRATION (FDA) FOR APPROVAL OF TETRAGRAPH IN UNITED STATES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below